Page last updated: 2024-09-03

dioscin and Bile Duct Obstruction, Intrahepatic

dioscin has been researched along with Bile Duct Obstruction, Intrahepatic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huo, X; Jia, Y; Liu, K; Liu, Q; Meng, Q; Peng, J; Sun, H; Sun, P; Wang, C; Xu, Q; Zhang, A	1

Other Studies

1 other study(ies) available for dioscin and Bile Duct Obstruction, Intrahepatic

Article	Year
Dioscin protects against ANIT-induced cholestasis via regulating Oatps, Mrp2 and Bsep expression in rats. Toxicology and applied pharmacology, 2016, 08-15, Volume: 305 Topics: 1-Naphthylisothiocyanate; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Cholestasis, Intrahepatic; Diosgenin; Estrone; Hepatocytes; Liver; Male; Multidrug Resistance-Associated Protein 2; Organic Anion Transporters; Protective Agents; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger	2016

Article

Year

Dioscin protects against ANIT-induced cholestasis via regulating Oatps, Mrp2 and Bsep expression in rats.

Toxicology and applied pharmacology, 2016, 08-15, Volume: 305

Topics: 1-Naphthylisothiocyanate; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Cholestasis, Intrahepatic; Diosgenin; Estrone; Hepatocytes; Liver; Male; Multidrug Resistance-Associated Protein 2; Organic Anion Transporters; Protective Agents; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; RNA, Messenger

2016